CV Lattes
ORCID
| 1 / 1 | Ongoing research grants |
| 4 / 4 | Completed research grants |
| 7 / 7 | Ongoing scholarships in Brazil |
| 23 / 22 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 4 / 4 | Completed scholarships abroad |
| 40 / 39 | All research grants and scholarships |
| Associated processes | |
Send your message by email
Advanced search
graduation at Ciências Biológicas Modalidade Médica from Centro Universitário Barão de Mauá (2004), master's at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2009) and doctorate at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2011). Has experience in Microbiology, acting on the following subjects: mycobacterium tuberculosis, maba, new drugs, anti-m. tuberculosis activity and novos fármacos. (Source: Lattes Curriculum)
| Articles published in Pesquisa para Inovação FAPESP about the researcher: |
| Scientists use chitosan to develop more stable antioxidant microparticles for cosmetics |
| More itemsLess items |
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Research grants
- 58th Conference of the Brazilian Society of Tropical Medicine (MEDTROP 2023), AR.BR
- Search for the mechanism of action and therapeutic effect of new classes of drugs against Mycobacterium tuberculosis, AP.R
- Development and search of new antimicrobials against Tuberculosis: from screening to pre-clinical studies in vivo, AP.R
(Only some records are available in English at this moment)
Scholarships in Brazil
- Evaluation of the therapeutic combination and cytotoxicity of compounds 5d, Tanshinone IIA and Cryptotanshinone with therapeutic drugs against Mycobacterium Tuberculosis and resistant clinical isolates., BP.IC
- Synthesis, characterization and evaluation of the in vitro activity of benzofuroxan derivatives against Mycobacterium tuberculosis., BP.IC
- Evaluation of the in vitro effect of analogues CR22-DKs12, CR22-BR04 and CR21-BR11 of the antimicrobial peptide B1CTcu5 in the inhibition of efflux pumps against macrophage infection by Mycobacterium tuberculosis., BP.IC
(Only some records are available in English at this moment)
- Evaluation of the in vivo therapeutic effect, mutagenicity and search for the mechanism of action of the compound 1-[1-(4-chlorophenyl)-2,5-dimethyl-pyrrole-3-yl]-N-(cyclohexylmethyl) methanamine, a derivative of N-phenyl-2,5-dimethylpyrrole, BP.DR
- Study of pathogenicity and virulence in strains of uropathogenic Escherichia coli ST131 producing KPC-2 in vitro and in vivo in an alternative model of Galleria melonella, BP.MS
- Evaluation of the against resistant Mycobacterium tuberculosis activity of N-acetylcysteine-chitosan nanoparticles conjugated with the antimicrobial peptide Ctx(Ile21)-Ha-Ahx-Cys loaded with rifampicin., BP.IC
(Only some records are available in English at this moment)
Scholarships abroad
- Evaluation of the inhibitory activity of analogs of the antimicrobial peptide B1CTcu5 in portuguese clinical isolates of extensively drug-resistant Mycobacterium tuberculosis and investigation of the mechanism of action, BE.EP.IC
- Drug discovery and design: antimicrobial peptide B1CTcu5 analogs promising against Mycobacterium tuberculosis, BE.EP.DR
- Molecular toxicology testing of benzofuraxanes, BE.EP.PD
(Only some records are available in English at this moment)
Total / Available in English